Arbutus Biopharma Corp (ABUS)
3.51
+0.05
(+1.45%)
USD |
NASDAQ |
Nov 22, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Shares Outstanding: 189.49M for Nov. 5, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 05, 2024 | 189.49M |
November 04, 2024 | 189.49M |
September 30, 2024 | 189.44M |
August 07, 2024 | 188.78M |
June 30, 2024 | 188.74M |
April 30, 2024 | 188.72M |
March 31, 2024 | 180.19M |
March 25, 2024 | 180.17M |
March 01, 2024 | 179.49M |
December 31, 2023 | 169.87M |
November 03, 2023 | 167.70M |
September 30, 2023 | 167.70M |
August 01, 2023 | 167.56M |
June 30, 2023 | 166.92M |
May 02, 2023 | 166.13M |
March 31, 2023 | 165.13M |
March 27, 2023 | 165.07M |
February 28, 2023 | 162.57M |
December 31, 2022 | 157.46M |
November 08, 2022 | 156.47M |
September 30, 2022 | 152.71M |
August 02, 2022 | 149.95M |
June 30, 2022 | 148.79M |
May 03, 2022 | 148.73M |
March 31, 2022 | 148.73M |
Date | Value |
---|---|
March 28, 2022 | 148.73M |
March 03, 2022 | 148.64M |
March 02, 2022 | 149.80M |
January 06, 2022 | 149.73M |
December 31, 2021 | 144.99M |
November 03, 2021 | 136.43M |
November 02, 2021 | 135.27M |
October 18, 2021 | 136.03M |
October 07, 2021 | 113.20M |
September 30, 2021 | 111.43M |
August 03, 2021 | 99.16M |
June 30, 2021 | 98.86M |
May 03, 2021 | 97.55M |
April 07, 2021 | 97.50M |
March 31, 2021 | 97.41M |
March 03, 2021 | 96.75M |
December 31, 2020 | 90.84M |
November 05, 2020 | 84.91M |
September 30, 2020 | 85.78M |
August 27, 2020 | 84.07M |
August 05, 2020 | 80.91M |
July 24, 2020 | 81.97M |
June 30, 2020 | 72.42M |
May 08, 2020 | 68.96M |
April 23, 2020 | 70.13M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
63.28M
Minimum
Dec 19 2019
189.49M
Maximum
Nov 04 2024
133.07M
Average
148.73M
Median
Mar 28 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Amicus Therapeutics Inc | 298.81M |
Ionis Pharmaceuticals Inc | 157.90M |
GlycoMimetics Inc | 64.48M |
FibroGen Inc | 100.77M |